Tonix Pharmaceuticals

TNXP trading on NASDAQ since 2009

Tonix Pharmaceuticals is a biopharmaceutical company focused on developing innovative treatments for central nervous system disorders and pain management through its pipeline of small-molecule medications.

type open high low market
cap
volume
stock $45.65 $61.20 $42.12 $342.04M 3.52M
eps p/e p/s operating
margin
profit
margin
yield
-$2.84 n/a 146.41 -660.93% -692.84% 0%